Overview
Labor induction is when an external agent is employed to stimulate contractions before the onset of spontaneous labor. On the other hand, labor augmentation uses the same techniques as labor induction, but uterine contractions (frequency, duration and strength) are enhanced once labor has started.
Labor induction is generally indicated when the benefits of delivery outweigh the risks of continuing the pregnancy.
Women at 42 weeks of gestation who chose not to undergo labor induction should be monitored more often with at least twice-weekly assessment of fetal well-being (cardiotocography and estimation of maximum amniotic pool depth by ultrasound).
Induction/augmentation can be achieved by pharmacotherapy (eg Prostaglandin E2, Misoprostol, Oxytocin, and Mifepristone) or by mechanical means like membrane sweeping, amniotomy, and balloon devices.
For further information regarding the management of Labor Induction, please refer to Disease Algorithm for the Treatment Guideline.
Labor induction is generally indicated when the benefits of delivery outweigh the risks of continuing the pregnancy.
Women at 42 weeks of gestation who chose not to undergo labor induction should be monitored more often with at least twice-weekly assessment of fetal well-being (cardiotocography and estimation of maximum amniotic pool depth by ultrasound).
Induction/augmentation can be achieved by pharmacotherapy (eg Prostaglandin E2, Misoprostol, Oxytocin, and Mifepristone) or by mechanical means like membrane sweeping, amniotomy, and balloon devices.
For further information regarding the management of Labor Induction, please refer to Disease Algorithm for the Treatment Guideline.
